InChI=1S/C30H35NO10/c1-6-30(38)12-19(41-20-11-17(31(3)4)25(33)13(2)40-20)22-15(24(30)29(37)39-5)10-16-23(28(22)36)27(35)21-14(26(16)34)8-7-9-18(21)32/h7-10,13,17,19-20,24-25,32-33,36,38H,6,11-12H2,1-5H3/t13-,17-,19-,20-,24-,25+,30+/m0/s1 |
LJZPVWKMAYDYAS-QKKPTTNWSA-N |
C1=CC=C(C2=C1C(C=3C=C4[C@H]([C@](C[C@@H](C4=C(C3C2=O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)N(C)C)(CC)O)C(=O)OC)=O)O |
|
antimicrobial agent
A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via anthracycline )
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
methyl (1R,2R,4S)-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-4-{[2,3,6-trideoxy-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate
|
1-deoxypyrromycin
|
ChemIDplus
|
aclacinomycin T
|
ChemIDplus
|
aklavin
|
ChemIDplus
|
aklavine
|
ChEBI
|
antibiotic MA 144T1
|
ChemIDplus
|
doxypyrromycin
|
ChemIDplus
|
MA 144T1
|
ChemIDplus
|
methyl (1R,2R,4S)-4-{[(2R,4S,5S,6S)-4-(dimethylamino)-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate
|
IUPAC
|
NSC 100290
|
ChemIDplus
|
Rhodosaminyl-aklavinone
|
KEGG COMPOUND
|
4898215
|
Reaxys Registry Number
|
Reaxys
|
60504-57-6
|
CAS Registry Number
|
KEGG COMPOUND
|
60504-57-6
|
CAS Registry Number
|
ChemIDplus
|
11004563
|
PubMed citation
|
SUBMITTER
|
11934504
|
PubMed citation
|
Europe PMC
|
12427929
|
PubMed citation
|
Europe PMC
|
12878604
|
PubMed citation
|
SUBMITTER
|
13345780
|
PubMed citation
|
Europe PMC
|
13345780
|
PubMed citation
|
Europe PMC
|
26216966
|
PubMed citation
|
Europe PMC
|
348304
|
PubMed citation
|
Europe PMC
|
591449
|
PubMed citation
|
Europe PMC
|
591449
|
PubMed citation
|
Europe PMC
|
|